Halda Therapeutics Names Dr. Eyal Attar as New Chief Medical Officer Halda Therapeutics, a clinical-stage biotechnology company pioneering a new class of cancer therapeutics, has announced the appointment of Dr. Eyal Attar as its Chief Medical Officer (CMO). The strategic…
EditCo Bio and Promega Team Up to Advance Cell-Based Research In a pivotal move set to reshape the landscape of functional genomics and cell engineering, EditCo Bio, Inc. has announced a strategic licensing agreement with Promega Corporation. This collaboration grants…
TNF Pharmaceuticals and Renova Health Harness AI to Fast-Track Drug Discovery In a significant advancement for data-driven drug development, TNF Pharmaceuticals has announced a strategic collaboration with Renova Health to harness artificial intelligence (AI) and machine learning (ML) technologies in…
Uniphar Expands Cell and Gene Therapy Portfolio with Tenth Project Milestone In a significant advancement that underscores its continued investment in next-generation healthcare solutions, Uniphar, a global leader in pharmaceutical and medtech services, has officially launched its 10th cell and…
QIAGEN Highlights Breakthroughs in Cancer Genomics and Announces Key Partnership Updates at AACR Annual Meeting 2025 QIAGEN N.V. Frankfurt Prime Standard: QIA), a global leader in molecular diagnostics and sample-to-insight technologies, today announced a comprehensive lineup of product innovations and…
6 Key Ways Pharmacists Contribute to Your Health and Wellbeing When it comes to managing your health in a fast-paced world, access to reliable, professional healthcare can make all the difference. While primary care physicians remain essential in diagnosing and…
Cytokinetics Announces Equity Awards Granted Under Nasdaq Listing Rule 5635(c)(4) Cytokinetics, Incorporated has taken another strategic step in fostering long-term company growth through a robust talent acquisition strategy that includes meaningful equity incentives. On April 15, 2025, the company announced…
EnPlusOne Biosciences Welcomes New CEO, Clare Murray, Ph.D. EnPlusOne Biosciences, Inc., a trailblazing biotechnology company pioneering enzyme-driven RNA synthesis technologies, announced today the appointment of Clare Murray, Ph.D., as its new Chief Executive Officer. The decision comes at a crucial…
Bruker Launches nVista 2P: A New Generation of Miniature Two-Photon Microscopes Bruker Corporation a global leader in scientific instruments and imaging technologies, has announced the launch of the nVista 2P, a next-generation miniature two-photon (2P) fluorescence microscope that brings deep-tissue,…
Flatiron Health Partners with Veeva to Advance Oncology Research In a significant development for the digital health and clinical research sectors, Flatiron Health—a pioneer in healthtech focused on transforming clinical research—has announced a new strategic partnership with Veeva Systems, a…
PursueCare to Highlight Digital Therapeutics at 2025 Rx Summit in Nashville PursueCare, a leader in virtual addiction treatment and medication-assisted therapy, is pleased to announce its participation in the 2025 Rx and Illicit Drug Summit, taking place April 21–24 in…
Tivic Health Expands Global License for TLR5 Agonist Entolimod to Include Neutropenia Treatment Tivic Health Systems, Inc. , a diversified therapeutics company focused on advancing innovative treatment solutions, has made a significant move in expanding its therapeutic pipeline. On March…